Our reporters bring you news and highlights from BIO’s in-person and virtual events.
As weakening investment plagues small, innovative biotechs on both sides of the Atlantic, one bright spot in providing funding is acquisitions—though even that vital …
M&A activity a bright spot in funding for biotech, expert tells 2023 BIO-Europe Read More »
Patients’ stories are powerful—especially when it comes to advocacy, agreed panelists at the Biotechnology Innovation Organization (BIO) Patient and Health Advocacy Summit. An October …
Patients are your best advocates – here’s how to support them Read More »
“We have 87 million patients in America who rely on Medicaid for either supplemental or primary coverage,” began Virginia McMillin of Jazz Pharmaceuticals during …
“Patient advocacy is at heart of what BIO is working to accomplish within this community to extend the lives of patients,” said Rachel King, …
Why patient advocacy is ‘at the heart’ of the biotech sector’s work Read More »
“The Inflation Reduction Act (IRA) was one of President Biden’s signature achievements and will help many Americans,” began Christina Hochul of Alexion Pharmaceuticals, Inc., …
Inflation Reduction Act: Unintended consequences for rare disease, orphan drugs Read More »
The Biotechnology Innovation Organization (BIO) Patient and Health Advocacy Summit is kicking off in Washington, D.C. Now in its 12th year, the event brings …
What we’re watching at the 2023 Patient & Health Advocacy Summit Read More »
The 2023 Biotechnology Innovation Organization (BIO) Investor Forum ended the way it began: with caution about the months ahead and hope companies will continue …
The market outlook for life science – and how biotechs can weather the storm Read More »
Artificial Intelligence (AI) is saturating every aspect of human life—including life sciences. While the potential of AI and computational biology are vast, one of …
How AI and computational biology can help us reach ‘undruggable’ targets Read More »
The wonder of RNA-based technology was long in its coming. But it has paid off throughout the COVID and post-COVID years. Plus, the breadth …
RNA presents challenges, enormous opportunities, say biotech leaders Read More »
The law on every company’s and investor’s mind: the Inflation Reduction Act (IRA), which allows the government to set the prices of certain drugs. …
How is the Inflation Reduction Act affecting biotech investment? Read More »
